Scipher Medicine Leadership to Present at the 40th Annual J.P. Morgan Healthcare Conference
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, today announced that Alif Saleh, chief executive officer, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022, at 8:30 a.m. ET.
Scipher Medicine, a precision immunology company matching each patient with their most effective therapy, believes that patients deserve simple answers to treatment options based on scientific data. Using Spectratm, our proprietary network medicine platform, we commercialize tests revealing a person's unique molecular disease signature and match it to the most effective therapy, ensuring optimal treatment from day one. The patient molecular data generated from our tests further supports the discovery and development of novel and more effective therapeutics. We partner with leading payers, health care providers, and pharmaceutical companies to bring solutions to patients with autoimmune diseases. Visit http://www.sciphermedicine.com and follow Scipher Medicine on Twitter, Facebook, and LinkedIn.
4WEB Medical, an orthopedic implant company focused on developing innovative implants that utilize its proprietary Truss Implant Technologytm, announced that it received regulatory clearance to market the newest addition to the company's anterior...
InfoMC Inc., a pioneer in medical management and behavioral health technology, and OptMyCare, a healthcare analytics company, today announced a partnership to integrate their technology solutions to optimize care orchestration and quality...
ReferralMD, a leader in healthcare technology solutions, is excited to announce the expansion of its Digital Front Door offering using the latest innovation in conversational AI. The Patient Registration & Intake Solution, powered...
Today, Orchard Software announced the availability of interface support for Antimicrobial Use and Resistance (AUR) reporting to the Centers for Disease Control and Prevention's (CDC) National Healthcare Safety Network (NHSN). Orchard's solutions send...
Biomarkers Market in terms of revenue was estimated to be worth $57.7 billion in 2024 and is poised to reach $93.8 billion by 2029, growing at a CAGR of 10.2% from 2024 to 2029 according to a new report by MarketsandMarketstm.
The growing...
The national "Seize the Awkward" campaign premiered a new digital content series today starring and directed by actress, activist, and creator Nia Sioux. The "Capture the Convo" series marks the former "Dance Moms" star and executive producer's debut...
